Pace Life Sciences, LLC, a contract development, and manufacturing organization (CDMO) and a division of Pace, a Science and Technology Company, has acquired Catalent Inc.’s Center-of-Excellence for Small Molecule Analytical Services located in Research Triangle Park (RTP), NC.
 
The acquired small molecule analytical services business has and will continue to support numerous biopharma and pharma clients with analytical services to bring life-changing medicines to market.
 
“This acquisition enhances and strengthens our ability to partner with our clients throughout early-stage drug research and development to commercialization as a full-service analytical outsourcing provider,” stated Eric Roman, President and CEO of Pace. “We are looking forward to the expansion of our scientific team and the expertise that comes with this transaction as we remain committed to our mission of improving lives and the health of our communities.”
 
Dawn Von Rohr, President of Pace Life Sciences, noted, “As we continue to expand our national network of small and large molecule testing services, we are able to provide faster, more flexible, and more reliable solutions for our clients. This commitment is the key accelerator for delivering high-quality laboratory services while tapping into our expertise to find solutions for complex programs.”
 
This transaction expands the Pace Life Sciences network to nine strategically located sites across the United States and Puerto Rico. These sites offer access to talented scientists and a wide range of services, including analytical services for small and large molecules, formulation development, and early-stage drug product manufacturing. All of these services are supported by a robust and validated quality system. Additionally, Pace provides key services in consulting, laboratory in-sourcing staffing, and laboratory equipment and relocation support.